NewsFeeder
Headline News
- Reaction score
- 4
Biogen Stock Could Have Run Up Too Far on Alzheimer’s Drug Revival
Shares were up as high as 37% in early trading after the biotech company seemingly erased its signal failure of the year. Some analysts are more cautious.
https://finance.yahoo.com/m/558026e...ea/biogen-stock-could-have-run.html?.tsrc=rss
Shares were up as high as 37% in early trading after the biotech company seemingly erased its signal failure of the year. Some analysts are more cautious.
https://finance.yahoo.com/m/558026e...ea/biogen-stock-could-have-run.html?.tsrc=rss
